COMMUNIQUÉ DE PRESSE publié le 08/12/2024 à 23:01, il y a 1 année 1 mois EQS-Adhoc: CompuGroup Medical SE & Co. KGaA confirms discussions for potential significant investment of CVC CompuGroup Medical SE & Co. KGaA in advanced discussions with CVC Capital Partners plc for potential investment agreement and public tender offer. Potential offer price of EUR 22.00 per share Public Tender Offer CompuGroup Medical Investment Agreement CVC Capital Partners EUR 22.00 Per Share
BRÈVE publiée le 07/11/2024 à 07:40, il y a 1 année 2 mois CompuGroup Medical Innovates Amid Q3 Earnings Decline Innovation Revenues CompuGroup Medical E-health Q3 Earnings
BRÈVE publiée le 07/11/2024 à 07:40, il y a 1 année 2 mois CompuGroup Medical innove malgré la baisse de ses résultats au troisième trimestre Innovation CompuGroup Medical Revenus E-santé Résultats Du Troisième Trimestre
COMMUNIQUÉ DE PRESSE publié le 07/11/2024 à 07:35, il y a 1 année 2 mois CGM drives innovation in the third quarter while recording earnings decline with almost stable revenues CompuGroup Medical records decline in earnings but drives innovation in the third quarter with almost stable revenues. Key focus on recurring revenues and new product launches Innovation CompuGroup Medical Product Launches Recurring Revenues Earnings Decline
BRÈVE publiée le 31/07/2024 à 18:45, il y a 1 année 6 mois CompuGroup Medical Appoints Prof. Dr. Daniel Gotthardt as New CEO Healthcare Technology CEO Appointment CompuGroup Medical Daniel Gotthardt Michael Rauch
BRÈVE publiée le 31/07/2024 à 18:45, il y a 1 année 6 mois CompuGroup Medical nomme le professeur Daniel Gotthardt au poste de nouveau PDG CompuGroup Medical Technologie De La Santé Nomination Du PDG Michael Rauch Daniel Gothardt
BRÈVE publiée le 31/07/2024 à 18:41, il y a 1 année 6 mois CompuGroup Medical SE & Co. KGaA nomme le professeur Daniel Gotthardt au poste de nouveau PDG CompuGroup Medical Changements Au Conseil D'administration Nomination D'un Nouveau PDG Michael Rauch Daniel Gothardt
BRÈVE publiée le 31/07/2024 à 18:41, il y a 1 année 6 mois CompuGroup Medical SE & Co. KGaA Appoints Prof. Dr. Daniel Gotthardt as New CEO Board Changes CompuGroup Medical New CEO Appointment Daniel Gotthardt Michael Rauch
COMMUNIQUÉ DE PRESSE publié le 31/07/2024 à 18:40, il y a 1 année 6 mois CompuGroup Medical appoints Prof. Dr. Daniel Gotthardt as new CEO CompuGroup Medical appoints Prof. Dr. Daniel Gotthardt as new CEO effective September 1, 2024. Previous CEO Michael Rauch to leave in mutual agreement. Company founder praises Rauch's contributions and highlights Gotthardt's medical background and entrepreneurial skills CEO Appointment CompuGroup Medical Prof. Dr. Daniel Gotthardt Company Founder Medical Background
COMMUNIQUÉ DE PRESSE publié le 31/07/2024 à 18:36, il y a 1 année 6 mois EQS-Adhoc: CompuGroup Medical SE & Co. KGaA appoints Prof. Dr. Daniel Gotthardt as new CEO CompuGroup Medical SE & Co. KGaA appoints Prof. Dr. Daniel Gotthardt as new CEO, terminating Michael Rauch's contract. Daniel Gotthardt to assume position on Sep 1, 2024 Termination CEO Appointment CompuGroup Medical Management Change Prof. Dr. Daniel Gotthardt
Publié le 05/02/2026 à 11:30, il y a 1 heure 36 minutes Déclaration nombre d'actions et droits de vote - 05.02.2026
Publié le 05/02/2026 à 11:30, il y a 1 heure 36 minutes Disclosure of shares outstanding and voting rights - 05.02.2026
Publié le 04/02/2026 à 18:04, il y a 19 heures 2 minutes Capital et droits de vote au 31 janvier 2026
Publié le 04/02/2026 à 18:04, il y a 19 heures 2 minutes Total number of voting rights and shares making up the share capital at January 31, 2026
Publié le 04/02/2026 à 17:45, il y a 19 heures 21 minutes Information concerning the total number of voting rights and shares 2026 01 31
Publié le 05/02/2026 à 12:30, il y a 36 minutes Relevant Gold Appoints Larry Taddei to Board of Directors and Mal Karwowska as Strategic Advisor
Publié le 05/02/2026 à 12:30, il y a 36 minutes Zomedica Announces "Fourth Friday at Four" Webinar on February 27th Focused on Research & Development and Its Innovation Pipeline
Publié le 05/02/2026 à 12:00, il y a 1 heure 6 minutes Datavault AI Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2025 Accomplishments and Outlook for 2026
Publié le 05/02/2026 à 09:05, il y a 4 heures 1 minute BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery
Publié le 05/02/2026 à 12:48, il y a 17 minutes Turkiye Garanti Bankasi A.S.: Announcement regarding forward looking statements on the expectations for the year 2026
Publié le 05/02/2026 à 11:47, il y a 1 heure 19 minutes Worthington Steel Announces Start of Acceptance Period for All-Cash Tender Offer of €11.00 per Share to Shareholders of Kloeckner & Co SE
Publié le 05/02/2026 à 11:45, il y a 1 heure 21 minutes EQS-WpÜG: Takeover Offer / Target company: Klöckner & Co SE; Bidder: Worthington Steel GmbH